Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides

Biochemistry

Volumn 42, Issue 12, 2003, Pages 3527-3535

  Yang, Rong ^a   Yang, Jun ^a   Weliky, David P ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED FUSOGENICITY;

CELL MEMBRANES; COMPOSITION; CROSSLINKING; LIPIDS; MONOMERS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERS; SYNTHESIS (CHEMICAL);

PROTEINS;

DIMER; GLYCOPROTEIN GP 41; HYBRID PROTEIN; MONOMER; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CROSS LINKING; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID COMPOSITION; MEMBRANE FUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SOLID STATE; TARGET CELL;

AMINO ACID SEQUENCE; CROSS-LINKING REAGENTS; DIMERIZATION; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; LIPIDS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, QUATERNARY; VIRAL FUSION PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037379448     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi027052g     Document Type: Article

References (71)

1. Hernandez, L. D., Hoffman, L. R., Wolfsberg, T. G., and White, J. M. (1996) Virus-cell and cell-cell fusion, Annu. Rev. Cell Dev. Biol. 12, 627-661.
2. Blumenthal, R., and Dimitrov, D. S. (1997) Membrane Fusion, in Handbook of Physiology, Section 14: Cell Physiology (Hoffman, J. F., and Jamieson, J. C., Eds.) pp 563-603, Oxford, New York.
3. Dimitrov, D. S. (2000) Cell biology of virus entry, Cell 101, 697-702.
4. Eckert, D. M., and Kim, P. S. (2001) Mechanisms of viral membrane fusion and its inhibition, Annu. Rev. Biochem. 70, 777-810.
5. Durell, S. R., Martin, I., Ruysschaert, J. M., Shai, Y., and Blumenthal, R. (1997) What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review), Mol. Membr. Biol. 14, 97-112.
6. Epand, R. F., Macosko, J. C., Russell, C. J., Shin, Y. K., and Epand, R. M. (1999) The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion, J. Mol. Biol. 286, 489-503.
7. Peisajovich, S. G., Epand, R. F., Pritsker, M., Shai, Y., and Epand, R. M. (2000) The polar region consecutive to the HIV fusion peptide participates in membrane fusion, Biochemistry 39, 1826-1833.
8. Peisajovich, S. G., Samuel, O., and Shai, Y. (2000) Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion, J. Mol. Biol. 296, 1353-1365.
9. Suarez, T., Gallaher, W. R., Agirre, A., Goni, F. M., and Nieva, J. L. (2000) Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion, J. Virol. 74, 8038-8047.
10. Sackett, K., and Shai, Y. (2002) The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion, Biochemistry 41, 4678-4685.
11. Freed, E. O., Myers, D. J., and Risser, R. (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41, Proc. Natl. Acad. Sci. U.S.A. 87, 4650-4654.
12. Freed, E. O., Delwart, E. L., Buchschacher, G. L., Jr., and Panganiban, A. T. (1992) A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity, Proc. Natl. Acad. Sci. U.S.A. 89, 70-74.
13. Schaal, H., Klein, M., Gehrmann, P., Adams, O., and Scheid, A. (1995) Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion, J. Virol. 69, 3308-3314.
14. Delahunty, M. D., Rhee, I., Freed, E. O., and Bonifacino, J. S. (1996) Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues, Virology 218, 94-102.
15. Pecheur, E., Sainte-Marie, J., Bienvenue, A., and Hoekstra, D. (1999) Peptides and membrane fusion: towards an understanding of the molecular mechanism of protein-induced fusion, J. Membr. Biol. 167, 1-17.
16. Rafalski, M., Lear, J. D., and DeGrado, W. F. (1990) Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41, Biochemistry 29, 7917-7922.
17. Slepushkin, V. A., Melikyan, G. B., Sidorova, M. S., Chumakov, V. M., Andreev, S. M., Manulyan, R. A., and Karamov, E. V. (1990) Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes, Biochem. Biophys. Res. Commun. 172, 952-957.
18. 2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes, Biochim. Biophys. Acta 1145, 124-133.
19. Nieva, J. L., Nir, S., Muga, A., Goni, F. M., and Wilschut, J. (1994) Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage, Biochemistry 33, 3201-3209.
20. Mobley, P. W., Lee, H. F., Curtain, C. C., Kirkpatrick, A., Waring, A. J., and Gordon, L. M. (1995) The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes, Biochim. Biophys. Acta 1271, 304-314.
21. Martin, I., Schaal, H., Scheid, A., and Ruysschaert, J. M. (1996) Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer, J. Virol. 70, 298-304.
22. Kliger, Y., Aharoni, A., Rapaport, D., Jones, P., Blumenthal, R., and Shai, Y. (1997) Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study, J. Biol. Chem. 272, 13496-13505.
23. Pereira, F. B., Goni, F. M., Muga, A., and Nieva, J. L. (1997) Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects, Biophys. J. 73, 1977-1986.
24. Nieva, J. L., Nir, S., and Wilschut, J. (1998) Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a beta-type structure of the HIV-1 fusion peptide, J. Liposome Res. 8, 165-182.
25. Pritsker, M., Rucker, J., Hoffman, T. L., Doms, R. W., and Shai, Y. (1999) Effect of nonpolar substitutions of the conserved Phe1-1 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes, Biochemistry 38, 11359-11371.
26. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994) Structure of influenza haemagglutinin at the pH of membrane fusion, Nature 371, 37-43.
27. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein, Cell 89, 263-273.
28. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41, Nature 387, 426-430.
29. Tan, K., Liu, J., Wang, J., Shen, S., and Lu, M. (1997) Atomic structure of a thermostable subdomain of HIV-1 gp41, Proc. Natl. Acad. Sci. U.S.A. 94, 12303-12308.
30. Caffrey, M., Cai, M., Kaufman, J., Stahl, S. J., Wingfield, P. T., Covell, D. G., Gronenborn, A. M., and Clore, G. M. (1998) Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41, EMBO J. 17, 4572-4584.
31. Yang, Z. N., Mueser, T. C., Kaufman, J., Stahl, S. J., Wingfield, P. T., and Hyde, C. C. (1999) The crystal structure of the SIV gp41 ectodomain at 1.47 Å resolution, J. Struct. Biol. 126, 131-144.
32. 2 subunit to form an N cap that terminates the triple-stranded coiled coil, Proc. Natl. Acad. Sci. U.S.A. 96, 8967-8972.
33. Carr, C. M., and Kim, P. S. (1993) A spring-loaded mechanism for the conformational change of influenza hemagglutinin, Cell 73, 823-832.
34. Wilson, I. A., Skehel, J. J., and Wiley, D. C. (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution, Nature 289, 366-373.
35. Bentz, J. (2000) Membrane fusion mediated by coiled coils: a hypothesis, Biophys. J. 78, 886-900.
36. Bentz, J. (2000) Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion, Biophys. J. 78, 227-245.
37. Kang, C. Y., Hariharan, K., Nara, P. L., Sodroski, J., and Moore, J. P. (1994) Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120, J. Virol. 68, 5854-5862.
38. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody, Nature 393, 648-659.
39. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., and Blumenthal, R. (1998) Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41, J. Cell Biol. 140, 315-323.
40. Chang, D. K., Cheng, S. F., and Chien, W. J. (1997) The aminoterminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface, J. Virol. 71, 6593-6602.
41. Glaser, R. W., Grune, M., Wandelt, C., and Ulrich, A. S. (1999) Structure analysis of a fusogenic peptide sequence from the sea urchin fertilization protein bindin, Biochemistry 38, 2560-2569.
42. Curtain, C., Separovic, F., Nielsen, K., Craik, D., Zhong, Y., and Kirkpatrick, A. (1999) The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids, Eur. Biophys. J. 28, 427-436.
43. Bradshaw, J. P., Darkes, M. J., Harroun, T. A., Katsaras, J., and Epand, R. M. (2000) Oblique membrane insertion of viral fusion peptide probed by neutron diffraction, Biochemistry 39, 6581-6585.
44. Taylor, S. E., Desbat, B., Blaudez, D., Jacobi, S., Chi, L. F., Fuchs, H., and Schwarz, G. (2000) Structure of a fusion peptide analogue at the air-water interface, determined from surface activity, infrared spectroscopy, and scanning force microscopy, Biophys. Chem. 87, 63-72.
45. Han, X., and Tamm, L. K. (2000) pH-dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers, J. Mol. Biol. 304, 953-965.
46. Yang, J., Gabrys, C. M., and Weliky, D. P. (2001) Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide, Biochemistry 40, 8126-8137.
47. Han, X., Bushweller, J. H., Cafiso, D. S., and Tamm, L. K. (2001) Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin, Nat. Struct. Biol. 8, 715-720.
48. Epand, R. M., Epand, R. F., Martin, I., and Ruysschaert, J. M. (2001) Membrane interactions of mutated forms of the influenza fusion peptide, Biochemistry 40, 8800-8807.
49. Hsu, C. H., Wu, S. H., Chang, D. K., and Chen, C. P. (2002) Structural characterizations of fusion peptide analogues of influenza virus hemagglutinin-Implication of the necessity of a helixhinge-helix motif in fusion activity, J. Biol. Chem. 277, 22725-22733.
50. Gordon, L. M., Mobley, P. W., Pilpa, R., Sherman, M. A., and Waring, A. J. (2002) Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using C-13-enhanced Fourier transform infrared spectroscopy, Biochim. Biophys. Acta 1559, 96-120.
51. Saez-Cirion, A., and Nieva, J. L. (2002) Conformational transitions of membrane-bound HIV-1 fusion peptide, Biochim. Biophys. Acta 1564, 57-65.
52. Yang, J., Parkanzky, P. D., Bodner, M. L., Duskin, C. G., and Weliky, D. P. (2002) Application of REDOR subtraction for filtered MAS observation of labeled backbone carbons of membrane-bound fusion peptides, J. Magn. Reson. 159, 101-110.
53. Kim, C. H., Macosko, J. C., Yu, Y. G., and Shin, Y. K. (1996) On the dynamics and confirmation of the HA2 domain of the influenza virus hemagglutinin, Biochemistry 35, 5359-5365.
54. Macosko, J. C., Kim, C. H., and Shin, Y. K. (1997) The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR, J. Mol. Biol. 267, 1139-1148.
55. Kim, C. H., Macosko, J. C., and Shin, Y. K. (1998) The mechanism for low-pH-induced clustering of phospholipid vesicles carrying the HA2 ectodomain of influenza hemagglutinin, Biochemistry 37, 137-144.
56. LeDuc, D. L., Shin, Y. K., Epand, R. F., and Epand, R. M. (2000) Factors determining vesicular lipid mixing induced by shortened constructs of influenza hemagglutinin, Biochemistry 39, 2733-2739.
57. Leikina, E., LeDuc, D. L., Macosko, J. C., Epand, R., Shin, Y. K., and Chernomordik, L. V. (2001) The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion, Biochemistry 40, 8378-8386.
58. Epand, R. F., Yip, C. M., Chernomordik, L. V., LeDuc, D. L., Shin, Y. K., and Epand, R. M. (2001) Self-assembly of influenza hemagglutinin: studies of ectodomain aggregation by in situ atomic force microscopy, Biochim. Biophys. Acta 1513, 167-175.
59. Han, X., and Tamm, L. K. (2000) A host-guest system to study structure-function relationships of membrane fusion peptides, Proc. Natl. Acad. Sci. U.S.A. 97, 13097-13102.
60. Aloia, R. C., Tian, H., and Jensen, F. C. (1993) Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes, Proc. Natl. Acad. Sci. U.S.A. 90, 5181-5185.
61. Hope, M. J., Bally, M. B., Webb, G., and Cullis, P. R. (1985) Production of large unilamellar vesicles by a rapid extrusion procedure-Characterization of size distribution, trapped volume, and ability to maintain a membrane-potential, Biochim. Biophys. Acta 812, 55-65.
62. Struck, D. K., Hoekstra, D., and Pagano, R. E. (1981) Use of resonance energy transfer to monitor membrane fusion, Biochemistry 20, 4093-4099.
63. Gullion, T., and Schaefer, J. (1989) Rotational-echo double-resonance NMR, J. Magn. Reson. 81, 196-200.
64. Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V., and Griffin, R. G. (1995) Heteronuclear decoupling in rotating solids, J. Chem. Phys. 103, 6951-6958.
65. Gullion, T., Baker, D. B., and Conradi, M. S. (1990) New, compensated Carr-Purcell sequences, J. Magn. Reson. 89, 479-484.
66. Gullion, T., and Schaefer, J. (1991) Elimination of resonance offset effects in rotational-echo, double-resonance NMR, J. Magn. Reson. 92, 439-442.
67. Wishart, D. S., Sykes, B. D., and Richards, F. M. (1991) Relationship between nuclear magnetic resonance chemical shift and protein secondary structure, J. Mol. Biol. 222, 311-333.
68. Chang, D. K., Cheng, S. F., and Trivedi, V. D. (1999) Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1. Implications on viral fusion mechanism, J. Biol. Chem. 274, 5299-5309.
69. Yang, J., and Weliky, D. P., unpublished experiments.
70. Lloyd-Williams, P., Albericio, F., and Giralt, E. (1997) Chemical Approaches to the Synthesis of Peptides and Proteins, CRC, Boca Raton, FL.
71. Parkanzky, P. D., and Weliky, D. P., unpublished experiments.